EurekaBio

EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), specializing in the research and development of core technologies and processes aimed at cost reduction and efficiency improvement. Renowned as a top domestic enterprise in cell preparation automation equipment, we have independently developed and introduced the CellSep® series of cell processing systems, along with sterile tubing welders, heat sealers, and wave reactors. These comprehensive solutions empower the production of cell therapy products. Additionally, our groundbreaking innovation, the EuLV® system, a globally leading lentiviral vector stable cell line technology, enables large-scale production of lentiviral vectors, effectively overcoming the technical challenge of scaling up production. The EuLV® system dramatically enhances production efficiency, ensures product consistency, and drives significant reductions in manufacturing costs.